Reduced O -GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney

dc.contributor.author	Hodrea, Judit
dc.contributor.author	Balogh, Dóra Bianka
dc.contributor.author	Hosszú, Ádám
dc.contributor.author	Lénárt, Lilla
dc.contributor.author	Besztercei, Balázs
dc.contributor.author	Kőszegi, Sándor
dc.contributor.author	Sparding, Nadja
dc.contributor.author	Genovese, Federica
dc.contributor.author	Wágner, László József
dc.contributor.author	Szabó, Attila
dc.contributor.author	Fekete, Andrea
dc.date.accessioned	2020-10-16T09:46:41Z
dc.date.available	2020-10-16T09:46:41Z
dc.date.issued	2020
dc.identifier.citation	journalVolume=318;journalIssueNumber=4;journalTitle=AMERICAN JOURNAL OF PHYSIOLOGY: RENAL PHYSIOLOGY;pagerange=F1017-F1029;journalAbbreviatedTitle=AM J PHYSIOL RENAL;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/8267
dc.identifier.uri	doi:10.1152/ajprenal.00021.2020
dc.format.extent	F1017-F1029
dc.relation.ispartof	urn:issn:1931-857X
dc.title	Reduced O -GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney
dc.type	Journal Article
dc.date.updated	2020-05-08T09:41:55Z
dc.language.rfc3066	en
dc.rights.holder	NULL
dc.identifier.mtmt	31205739
dc.identifier.pubmed	32116017
dc.contributor.department	SE/AOK/K/I. Sz. Gyermekgyógyászati Klinika
dc.contributor.department	SE/AOK/K/ISZGYK/MTA-SE Lendület Diabétesz Kutatócsoport
dc.contributor.department	SE/AOK/I/Transzlációs Medicina Intézet
dc.contributor.institution	Semmelweis Egyetem